Abstract:Background: Xerostomia, or dry mouth, can be a temporary or persistent symptom resulting from various factors, such as medication use, therapeutic radiation, chemotherapy, autoimmune conditions (e.g., Sjögren's syndrome), and hormonal imbalances. Xerostomia often leads to associated mucositis, which significantly impacts patients' quality of life. The nano-bio-fusion (NBF) gingival gel, a gel-type functional toothpaste containing vitamins C, E, propolis, and herbal extracts in a nano-emulsion state, has shown potential in accelerating the healing of oral mucosal lesions. Methods: A total of 127 patients (102 females, 25 males) with persistent xerostomia were treated from 2018 to 2023. Of these, 32 patients were treated exclusively with NBF Gel, while 95 patients received NBF Gel in combination with other medications, such as pilocarpine. The underlying causes of xerostomia included irradiation and chemotherapy (12 patients), medication (40 patients), hormonal imbalance (28 patients), and Sjögren's syndrome (47 patients). NBF Gel was applied 2-3 times daily to the tongue and oral mucosa. Treatment effectiveness was evaluated through physical examinations and a patient-reported scale ranging from 1 (no improvement) to 10 (complete improvement), focusing on the healing of mucosal lesions rather than saliva production. Results: Both treatment groups showed significant improvements in the healing of xerostomia-associated mucositis, particularly in severe cases with visible lesions. Patients treated with NBF Gel reported improved symptoms related to mucosal health, while those who received combination therapy also experienced reduced side effects of pilocarpine due to dose reduction. The most substantial improvements were observed in patients with drug-induced and hormonally-caused xerostomia-related mucositis. No adverse side effects from NBF Gel were reported during the study. Conclusion: NBF gingival gel proved to be beneficial in accelerating the healing of mucositis associated with xerostomia, regardless of the underlying cause, including medication use, radiotherapy, chemotherapy, hormonal imbalances, and Sjögren's syndrome. It presents a promising adjunctive treatment to improve mucosal health and quality of life for patients suffering from xerostomia-associated mucositis.

An imaging-based approach to the evaluation of xerostomia.

Effect of Electrical Stimulation of Lingual Nerve on Xerostomia: A Randomized Controlled Trial

Modern approaches to the diagnosis of xerostomia

World Workshop on Oral Medicine VIII: Development of a Core Outcome Set for Dry Mouth: A Systematic Review of Outcome Domains for Xerostomia.

Comprehensive investigation of saliva replacement liquids for the treatment of xerostomia

Clinical Comparison on the Effect of Β-Glucan/citric Acid Spray and Optimoisttm Spray in Treatment of Xerostomia

In Vivo Imaging of Oral Mucositis in an Animal Model Using Optical Coherence Tomography and Optical Doppler Tomography

Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region

Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia

Quantitative assessment of the oral microvasculature using optical coherence tomography angiography

Efficacy and Safety of an Intraoral Electrostimulation Device for Xerostomia Relief A Multicenter, Randomized Trial

Imaging Biomarkers of Oral Dysplasia and Carcinoma Measured with In Vivo Endoscopic Optical Coherence Tomography

Intraoral Electrostimulator for Xerostomia Relief: a Long-Term, Multicenter, Open-Label, Uncontrolled, Clinical Trial

Impact of 1% malic acid spray on the oral health-related quality of life of patients with xerostomia

Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial

Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review

In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients.

Metabolomic insights into idiopathic xerostomia: The central role of caffeine metabolism in salivary biochemistry

Clinical outcomes of NBF gel application in managing mucositis associated with xerostomia

Noninvasive imaging of oral premalignancy and malignancy

Optical coherence tomography: Promising imaging technique for the diagnosis of oral mucosal diseases